| 2026-10-27 | Herabstufung | UBS | Buy → Neutral |
| 2026-10-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-10-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-09-23 | Eingeleitet | FBN Securities | Sector Perform |
| 2026-08-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2026-08-06 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2026-08-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-08-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2026-08-06 | Herabstufung | Stifel | Buy → Hold |
| 2026-07-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-05-11 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2026-05-11 | Herabstufung | Macquarie | Outperform → Neutral |
| 2026-05-08 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-05-08 | Herabstufung | BofA Securities | Buy → Underperform |
| 2026-05-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2026-05-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-05-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2026-03-31 | Resumed | BofA Securities | Buy |
| 2026-01-29 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-01-05 | Resumed | BTIG Research | Buy |
| 2025-12-17 | Eingeleitet | BTIG Research | Buy |
| 2025-11-10 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-10-24 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-01 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-03 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-08-07 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-08-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-07-18 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-06-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-05-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-04-22 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2025-04-15 | Hochstufung | UBS | Neutral → Buy |
| 2025-03-24 | Eingeleitet | Macquarie | Outperform |
| 2025-03-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2025-03-19 | Eingeleitet | Stephens | Overweight |
| 2025-03-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-19 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-02-13 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-17 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-11-07 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-11-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-08-08 | Hochstufung | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2024-05-09 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Underweight |
| 2023-12-12 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-30 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-11-14 | Eingeleitet | CapitalOne | Overweight |
| 2023-10-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-02 | Eingeleitet | Macquarie | Outperform |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-09 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-26 | Eingeleitet | UBS | Neutral |
| 2022-02-11 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-12-13 | Eingeleitet | Goldman | Buy |
| 2021-11-04 | Bestätigt | Cowen | Market Perform |
| 2021-11-04 | Bestätigt | Evercore ISI | In-line |
| 2021-11-04 | Bestätigt | Mizuho | Buy |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Raymond James | Strong Buy |
| 2021-11-04 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-21 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-10-13 | Resumed | RBC Capital Mkts | Outperform |
| 2021-09-30 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-07-26 | Bestätigt | BofA Securities | Buy |
| 2021-04-23 | Eingeleitet | Wolfe Research | Outperform |
| 2021-04-08 | Resumed | BofA Securities | Buy |
| 2021-04-07 | Resumed | Stifel | Buy |
| 2021-03-03 | Resumed | Citigroup | Buy |
| 2021-02-12 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-02-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-19 | Eingeleitet | Argus | Buy |
| 2020-07-16 | Eingeleitet | Citigroup | Buy |
| 2020-07-08 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-03-25 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-01-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-27 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-10 | Eingeleitet | Mizuho | Buy |
| 2019-11-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-09-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-13 | Eingeleitet | Compass Point | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Buy |
| 2019-03-20 | Resumed | Guggenheim | Buy |
| 2019-02-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-02-13 | Bestätigt | Canaccord Genuity | Buy |
| 2019-02-13 | Bestätigt | Needham | Buy |
| 2019-01-24 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-01-23 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-17 | Eingeleitet | Stephens | Overweight |
| 2018-10-04 | Eingeleitet | Rosenblatt | Buy |
HUBS
